My ePortfolio Register   
 

Abstract | Full HTML Article | PDF ecancer 10 610 / DOI: 10.3332/ecancer.2016.610

Clinical Study

Repurposing Drugs in Oncology (ReDO)—diclofenac as an anti-cancer agent

Diclofenac (DCF) is a well-known and widely used non-steroidal anti-inflammatory drug (NSAID), with a range of actions which are of interest in an oncological context. While there has long been an interest in the use of NSAIDs in chemoprevention, there is now emerging evidence that such drugs may have activity in a treatment setting. DCF, which is a potent inhibitor of COX-2 and prostaglandin E2 synthesis, displays a range of effects on the immune system, the angiogenic cascade, chemo- and radio-sensitivity and tumour metabolism. Both pre-clinical and clinical evidence of these effects, in multiple cancer types, is assessed and summarised and relevant mechanisms of action outlined. Based on this evidence the case is made for further clinical investigation of the anticancer effects of DCF, particularly in combination with other agents - with a range of possible multi-drug and multi-modality combinations outlined in the supplementary materials accompanying the main paper.

Keywords: Drug repurposing, diclofenac, NSAID, perioperative intervention, ReDO project

Loading Article Metrics ... Please wait

Related articles

Clinical Study: Diagnostic and therapeutic update of mantle cell lymphoma (MCL): analysis of seven cases treated in a centre in one year

Abstract | Full Article | PDF | Spanish Published: 17 Mar 2016 / DOI: 10.3332/ecancer.2016.627

Conference Report: Highlights from the 38th SABCS annual meeting, 8th – 12th December 2015, San Antonio, USA

Abstract | Full Article | PDF Published: 02 Feb 2016 / DOI: 10.3332/ecancer.2016.618

Conference Report: Highlights of the eleventh annual meeting of the National Cancer Research Institute, 1–4 November 2015, Liverpool, UK

Abstract | Full Article | PDF Published: 21 Jan 2016 / DOI: 10.3332/ecancer.2016.615

Policy: An Association of Cancer Physicians’ strategy for improving services and outcomes for cancer patients

Abstract | Full Article | PDF Published: 05 Jan 2016 / DOI: 10.3332/ecancer.2016.608

Policy: Costs of breast cancer care in Mexico: analysis of two insurance coverage scenarios

Abstract | Full Article | PDF | Portuguese | Spanish Published: 28 Oct 2015 / DOI: 10.3332/ecancer.2015.587



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence